Geneva, March 20 -- International Clinical Trials Registry received information related to the study (CTRI/2026/02/104860) titled 'A study to compare two oral medicines for treating psoriasis in children and adolescents' on Feb. 26.
Study Type: Interventional
Study Design:
Randomized, Parallel Group, Active Controlled Trial Method of generating randomization sequence:Permuted block randomization, fixed Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Open Label
Primary Sponsor: Postgraduate Institute of Medical Education and Research
Condition:
Health Condition 1: L400- Psoriasis vulgaris
Intervention:
Intervention1: Apremilast: Patients will receive tablet apremilast 20 mg ...